Key Studies in Gastrointestinal Cancers from the 2020 ASCO Virtual Scientific Meeting

May 29-31, 2020; Online at meetings.asco.org/am
Download this slideset for expert perspectives on the most clinically relevant data on colorectal, gastroesophageal, and pancreatic cancers presented at the 2020 ASCO Virtual Scientific Meeting.
Axel Grothey Headshot
Axel Grothey, MD
Manish A. Shah, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 581 KB
Released: August 7, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
Daiichi Sankyo, Inc.

Related Content

In this short slideset from Clinical Care Options (CCO), experts review the role of PARP inhibitors in the maintenance setting for metastatic pancreatic cancer

person default Paul E. Oberstein, MD
Program Director
Released: March 5, 2021

Video of expert discussion on the role of PARP inhibitors in the maintenance setting for metastatic pancreatic cancer from Clinical Care Options (CCO)

person default Paul E. Oberstein, MD
Program Director
Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 5, 2021 Expired: March 4, 2022

Video of expert discussion on neoadjuvant/adjuvant therapy for resectable pancreatic cancer from Clinical Care Options (CCO)

person default Paul E. Oberstein, MD
Program Director
Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 1, 2021 Expired: February 28, 2022

In this short slideset from Clinical Care Options (CCO), experts review neoadjuvant/adjuvant therapy for resectable pancreatic cancer

person default Paul E. Oberstein, MD
Program Director
Released: March 1, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue